Published on: July 08, 2020 at 09:30PM
Conditions: Cardiovascular Diseases; Left Ventricular Hypertrophy
Interventions: Drug: Empagliflozin; Drug: Placebo
Sponsors: St. Michael's Hospital, Toronto; Canadian Medical and Surgical Knowledge Translation Research Group; Boehringer Ingelheim; Applied Health Research Centre
Not yet recruiting
https://ift.tt/2CbfyOd
Wednesday, 8 July 2020
New diabetes clinical trial: Empagliflozin and Cardiac Remodelling in People Without Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.